RecruitingPhase 3NCT06959095
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Sponsor: GlaxoSmithKline
Franklin, TN · +41 more sites
5 recruiting copd studies with a site in Franklin, TN.
Sponsor: GlaxoSmithKline
Franklin, TN · +41 more sites
Sponsor: AstraZeneca
Chattanooga, TN · Elizabethton, TN · Franklin, TN · +232 more sites
Sponsor: AstraZeneca
Chattanooga, TN · Franklin, TN · Johnson City, TN · +83 more sites
Sponsor: AstraZeneca
Franklin, TN · Johnson City, TN · +71 more sites
Sponsor: Pfizer
Franklin, TN · Hendersonville, TN · +59 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.